Cardiovascular disease in survivors of hematopoietic cell transplantation
Key result
Survivors of hematopoietic cell transplantation face an increased risk of premature cardiovascular disease associated with therapeutic exposures and traditional risk factors.
Population
Survivors of hematopoietic cell transplantation (HCT)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May warrant enhanced CVD surveillance in HCT survivors; leaves open optimal screening protocols for prospective trials.
Structured PICO
P
Population
Survivors of hematopoietic cell transplantation (HCT)
This review highlights the increased risk of premature cardiovascular disease in hematopoietic cell transplantation survivors and emphasizes the need for surveillance and risk factor management.
Cite This Study
Armenian et al. (2013) conducted a review in Hematopoietic cell transplantation survivors. Survivors of hematopoietic cell transplantation face an increased risk of premature cardiovascular disease associated with therapeutic exposures and traditional risk factors.